A PCA3 gene-based transcriptional amplification system targeting primary prostate cancer.
about
Investigation of the In Vitro and In Vivo efficiency of RM-532-105, a 17β-hydroxysteroid dehydrogenase type 3 inhibitor, in LAPC-4 prostate cancer cell and tumor modelsRisk assessment models to evaluate the necessity of prostate biopsies in North Chinese patients with 4-50 ng/mL PSA.Long Non-Coding RNA as Potential Biomarker for Prostate Cancer: Is It Making a Difference?Bioluminescence Microscopy as a Method to Measure Single Cell Androgen Receptor Activity Heterogeneous Responses to AntiandrogensEmerging and Established Models of Bone Metastasis.
P2860
A PCA3 gene-based transcriptional amplification system targeting primary prostate cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A PCA3 gene-based transcriptional amplification system targeting primary prostate cancer.
@en
type
label
A PCA3 gene-based transcriptional amplification system targeting primary prostate cancer.
@en
prefLabel
A PCA3 gene-based transcriptional amplification system targeting primary prostate cancer.
@en
P2093
P2860
P356
P1433
P1476
A PCA3 gene-based transcriptional amplification system targeting primary prostate cancer.
@en
P2093
Bernard Têtu
Bertrand Neveu
Frédéric Pouliot
Pallavi Jain
Yves Fradet
P2860
P304
P356
10.18632/ONCOTARGET.6360
P407
P577
2015-11-22T00:00:00Z